Research Progresses on Pharmaceutical Co-crystals of the Cardiovascular and Cerebrovascular Diseases Treatment Drugs / 医药导报
Herald of Medicine
; (12): 187-192, 2019.
Article
en Zh
| WPRIM
| ID: wpr-744212
Biblioteca responsable:
WPRO
ABSTRACT
The pharmaceutical co-crystal has attracted a lot of attention in recent years as a new direction in the research of polymorphism drugs. The research on pharmaceutical co-crystal has scientific significance for improving the solubility, bioavailability and physical or chemical stability of drugs. In this paper, from the perspective of drugs for the treatment of cardiovascular diseases(including five major types heart failure, hypertension, coronary heart disease and arrhythmia, stroke) , the latest research results of pharmaceutical co-crystal reported in recent years are reviewed, hope to provide reference for the follow-up research and promote the development of pharmaceutical co-crystal in China.
Texto completo:
1
Banco de datos:
WPRIM
Idioma:
Zh
Año:
2019
Tipo del documento:
Article